Methods for inhibiting the development, formation and/or maturation of bacterial and fungal biofilms
CA2936070A1
Poloxamer-based intralesional injections for the delivery of chemotherapeutic agents
US2016310595A1
Mucoadhesive dental gel including apis
CA2919648A1
Natural solubilizer agent comprising a synergistic blend of heptyl glucoside and olive oil glycereth-8 esters for transdermal compositions
CA2919673A1
Use of heptyl glucoside as skin penetration enhancer in transdermal pharmaceutical compositions
US2016051686A1
Pharmaceutical compositions for treating ear diseases
US2016051607A1
Topical pharmaceutical bases for preventing viral diseases
US2016051609A1
Topical pharmaceutical bases for treating inflammatory disorders
US2016051497A1
Transdermal pharmaceutical compositions including C-SERMs for low testosterone levels in men
CA2958864A1
Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
US2016051684A1
Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions
US2016051564A1
Oral transmucosal pharmaceutical compositions including testosterone and a C-SERM
US2015250727A1
Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
US2014371211A1
Piroxicam transdermal composition to treat plantar fasciitis
